Is Caffeine legal in Myanmar?

Legal status

Controlled in Myanmar as a designated precursor, not as a narcotic drug or psychotropic substance. Ministry of Health Notification 26/2025, dated 25 February 2025, lists in paragraph 1(c), the precursors designated for Myanmar's own needs, at serial 3 «ကေဖင်း (Caffeine)» with the chemical name «1,3,7-trimethylpurine-2,6-dione». Section 16(b) of the Narcotic Drugs and Psychotropic Substances Law, as substituted by Law 6/2018, reaches «possession, transport, distribution or sale, without permission by this Law, of precursors which are announced to be substances or of related materials used in the production of narcotic drugs and psychotropic substances by notification of the Ministry». Caffeine is not listed in Notification 24/2025 or 25/2025, so it is not a narcotic drug or psychotropic substance under section 2. The paragraph and serial numbers in this cell are read from the notification's page images and are not printed in the quoted extract the dossier carries for this row; the notification's headings are in Burmese and are translated by this record, while the English name and chemical name are printed in the notification.

Consequences if caught

Capital exposure: none on the text. Section 20, the only article that reaches death, takes a narcotic drug or psychotropic substance as its object, and caffeine is listed only as a precursor. The offence is section 16(b): possession, transport, distribution or sale of a notified precursor without permission is punished with imprisonment from a minimum of 5 years to a maximum of 10 years, and a fine may also be imposed. Paragraph 2 of Notification 26/2025, read here from its Burmese text and translated by this record, requires a recommendation or permit under paragraph 3 to produce, research, use, possess, store, sell, transport, transit, transfer, import or export the listed precursors. It excepts precursors that are not for use in producing narcotic drugs or psychotropic substances when they are in medicines made with them and used for treatment, at paragraph 2(a), or in compounds from which the precursor cannot readily be separated and reused, at paragraph 2(b), which the notification illustrates with battery acid, cosmetic oil, fragrances, perfume, scented soap, dye, rust remover, paint and fertiliser. Paragraph 2(c), the allowance for household, personal and business quantities, lists seven chemicals with a quantity for each, and caffeine is not among them. On that reading, caffeine powder, which is neither a medicine nor such a compound, needs a permit in any amount, and possessing or carrying it without one falls under section 16(b). The notification does not say whether a caffeine tablet or capsule that is not a medicine counts as a compound from which the caffeine cannot readily be recovered. Section 26, as Law 17/2025 replaced it, sets its deemed sale quantities for narcotic drugs and psychotropic substances, so no deemed quantity applies to caffeine.

If prescribed or medical

Paragraph 2(a) of Notification 26/2025, as translated here, takes medicines made with a listed precursor out of the recommendation or permit requirement, and paragraph 2(d) does the same for use, possession and transport by registered doctors and patients in accordance with the Ministry of Health's instructions. So a caffeine containing medicine carried for treatment is outside the permit requirement on that reading. No other prescription rule for caffeine was read.

Documentation

No document is needed under this Law for caffeine in a medicine used for treatment, or in a compound from which it cannot readily be recovered, on the reading of paragraph 2 of Notification 26/2025 set out in this cell. Possessing, storing or transporting caffeine powder, in any amount, needs the permit that paragraph 3(c) describes, from the committee for the control of precursor chemicals or the drug control bodies it delegates to, and paragraph 2 requires a recommendation or permit under paragraph 3 to import it; paragraph 3(a) sets the committee's prior recommendation for the business of importing or exporting precursors and names no separate route for a traveller. Paragraph 2(c)'s allowance for household, personal and business quantities does not list caffeine. The notification does not say whether a caffeine tablet or capsule that is not a medicine needs the same. A document issued outside Myanmar is not that permit or recommendation. Medicines, import and customs rules sit outside the narcotics law and were not read for this cell. The Law was further amended by the Second Amendment to the Narcotic Drugs and Psychotropic Substances Law, National Defence and Security Council Law 17/2025, enacted on 31 December 2025, whose English text was published in the Global New Light of Myanmar on 7 January 2026, pages 3 and 5. That text carries no separate commencement clause. Among other changes, it replaced section 26, the deemed sale quantities, restored the expression «the Ministry of Health», replaced «Coca tree» with «Coca» in sections 2(a)(i) and 16(a), replaced the expression «life imprisonment without limit» in sections 19 and 20 with «life imprisonment», which its new section 2(i) defines, leaving the death alternative in section 20 in place, and raised the age in section 22(c) from 16 to 18; the other fields of this cell apply the Law as amended by it. The English text read is a newspaper publication of the law, not the official Burmese text.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Myanmar’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.